Buscar
Omeros Corp
OMERAñadir a la lista de seguimiento
11.850USD
-0.080-0.67%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
830.37MCap. mercado
9.09P/E TTM
Más Datos de Omeros Corp Compañía
Omeros Corporation is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting immunologic disorders, including complement-mediated diseases, cancers, and addictive and compulsive disorders. Its lead MASP-2 inhibitor, narsoplimab, targets the lectin pathway of complement and is the subject of a biologics license application pending before FDA for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy. Its long-acting MASP-2 inhibitor, OMS1029, is in phase I single- and multiple-ascending-dose clinical studies. OMS906, its inhibitor of MASP-3, the key activator of the alternative pathway of complement, is advancing in clinical programs for paroxysmal nocturnal hemoglobinuria and complement 3 glomerulopathy. Its lead phosphodiesterase 7 inhibitor OMS527 is in clinical development for the treatment of cocaine use disorders.
Información de Omeros Corp
Símbolo de cotizaciónOMER
Nombre de la empresaOmeros Corp
Fecha de salida a bolsaOct 08, 2009
Director ejecutivoDemopulos (Gregory A)
Número de empleados202
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 08
Dirección201 Elliott Avenue West
CiudadSEATTLE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal98119
Teléfono12066765000
Sitio Webhttps://www.omeros.com/
Símbolo de cotizaciónOMER
Fecha de salida a bolsaOct 08, 2009
Director ejecutivoDemopulos (Gregory A)
Ejecutivos de Omeros Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Peter A. Demopulos, M.D.
Dr. Peter A. Demopulos, M.D.
Director
Director
972.90K
+61.67%
Dr. Leroy E. Hood, M.D., Ph.D.
Dr. Leroy E. Hood, M.D., Ph.D.
Independent Director
Independent Director
74.39K
--
Mr. Thomas J. Cable
Mr. Thomas J. Cable
Lead Independent Director
Lead Independent Director
35.07K
--
Mr. Arnold C. Hanish, CPA
Mr. Arnold C. Hanish, CPA
Independent Director
Independent Director
12.40K
--
Mr. David W. Ghesquiere
Mr. David W. Ghesquiere
Vice President, Chief Business Development Officer
Vice President, Chief Business Development Officer
--
--
DR. Gregory A. Demopulos, M.D.
DR. Gregory A. Demopulos, M.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Dr. Rajiv Shah, M.D.
Dr. Rajiv Shah, M.D.
Independent Director
Independent Director
--
--
Dr. Thomas F. Bumol, Ph.D.
Dr. Thomas F. Bumol, Ph.D.
Independent Director
Independent Director
--
--
Dr. George A. Gaitanaris, M.D., Ph.D.
Dr. George A. Gaitanaris, M.D., Ph.D.
Vice President - Science, Chief Scientific Officer
Vice President - Science, Chief Scientific Officer
--
--
Dr. Catherine A. Melfi, Ph.D.
Dr. Catherine A. Melfi, Ph.D.
Vice President - Regulatory Affairs and Quality Systems, Chief Regulatory Officer
Vice President - Regulatory Affairs and Quality Systems, Chief Regulatory Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Peter A. Demopulos, M.D.
Dr. Peter A. Demopulos, M.D.
Director
Director
972.90K
+61.67%
Dr. Leroy E. Hood, M.D., Ph.D.
Dr. Leroy E. Hood, M.D., Ph.D.
Independent Director
Independent Director
74.39K
--
Mr. Thomas J. Cable
Mr. Thomas J. Cable
Lead Independent Director
Lead Independent Director
35.07K
--
Mr. Arnold C. Hanish, CPA
Mr. Arnold C. Hanish, CPA
Independent Director
Independent Director
12.40K
--
Mr. David W. Ghesquiere
Mr. David W. Ghesquiere
Vice President, Chief Business Development Officer
Vice President, Chief Business Development Officer
--
--
DR. Gregory A. Demopulos, M.D.
DR. Gregory A. Demopulos, M.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Omeros Corp?
Los cinco principales accionistas de Omeros Corp son: Dr. Peter A. Demopulos, M.D.
¿Cuántas instituciones poseen acciones de Omeros Corp (OMER)?
A fecha de 2026Q1, 290 instituciones poseen acciones de Omeros Corp, con un valor de mercado combinado de aproximadamente 38.03M, lo que representa el 52.70% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 1795629.00.